Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr-Jun;14(2):91-98.
doi: 10.1080/23294515.2022.2160509. Epub 2022 Dec 28.

A Content Analysis of Self-Reported Financial Relationships in Biomedical Research

S Scott Graham  1 , Nandini Sharma  2 , Martha S Karnes  3 , Zoltan P Majdik  4 , Joshua B Barbour  2 , Justin F Rousseau  5
Affiliations

A Content Analysis of Self-Reported Financial Relationships in Biomedical Research

S Scott Graham et al. AJOB Empir Bioeth. 2023 Apr-Jun.

Abstract

Introduction: Financial conflicts of interest (fCOI) present well documented risks to the integrity of biomedical research. However, few studies differentiate among fCOI types in their analyses, and those that do tend to use preexisting taxonomies for fCOI identification. Research on fCOI would benefit from an empirically-derived taxonomy of self-reported fCOI and data on fCOI type and payor prevalence.

Methods: We conducted a content analysis of 6,165 individual self-reported relationships from COI statements distributed across 378 articles indexed with PubMed. Two coders used an iterative coding process to identify and classify individual fCOI types and payors. Inter-rater reliability was κ = 0.935 for fCOI type and κ = 0.884 for payor identification.

Results: Our analysis identified 21 fCOI types, 9 of which occurred at prevalences greater than 1%. These included research funding (24.8%), speaking fees (20.8%), consulting fees (18.8%), advisory relationships (11%), industry employment (7.6%), unspecified fees (4.8%), travel fees (3.2%), stock holdings (3.1%), and patent ownership (1%). Reported fCOI were held with 1,077 unique payors, 22 of which were present in more than 1% of financial relationships. The ten most common payors included Pfizer (4%), Novartis (3.9%), MSD (3.8%), Bristol Myers Squibb (3.2%), AstraZeneca (3.1%), GSK (3%), Boehringer Ingelheim (2.9%), Roche (2.8%), Eli LIlly (2.5%), and AbbVie (2.4%).

Conclusions: These results provide novel multi-domain prevalence data on self-reported fCOI and payors in biomedical research. As such, they have the potential to catalyze future research that can assess the differential effects of various types of fCOI. Specifically, the data suggest that comparative analyses of the effects of different fCOI types are needed and that special attention should be paid to the diversity of payor types for research relationships.

Keywords: Conflict of interest; drug industry; ethics; health policy; research.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

There are no conflicts of interest to report.

Figures

Figure 1:
Figure 1:
Frequency of fCOI type among top 10 payors.
See this image and copyright information in PMC

References

    1. Ahmer Syed, Arya Pradeep, Anderson Duncan, and Faruqui Rafey. 2005. “Conflict of Interest in Psychiatry.” Psychiatric Bulletin 29 (8): 302–4. 10.1192/pb.29.8.302. - DOI
    1. Ahn Rosa, Woodbridge Alexandra, Abraham Ann, Saba Susan, Korenstein Deborah, Madden Erin, Boscardin W. John, and Keyhani Salomeh. 2017. “Financial Ties of Principal Investigators and Randomized Controlled Trial Outcomes: Cross Sectional Study.” BMJ 356 (January): i6770. 10.1136/bmj.i6770. - DOI - PMC - PubMed
    1. Als-Nielsen Bodil, Chen Wendong, Gluud Christian, and Kjaergard Lise L.. 2003. “Association of Funding and Conclusions in Randomized Drug TrialsA Reflection of Treatment Effect or Adverse Events?” JAMA 290 (7): 921–28. 10.1001/jama.290.7.921. - DOI - PubMed
    1. Bellomo Tiffany R., Hwang Charles, and Corriere Matthew A.. 2019. “Scope and Prevalence of Conflicts of Interest Among Highly Cited Peripheral Artery Disease Research Studies.” Journal of Vascular Surgery 69 (1): e7–8. 10.1016/j.jvs.2018.10.018. - DOI - PubMed
    1. Bighelli Irene, Leucht Claudia, Huhn Maximilian, Reitmeir Cornelia, Schwermann Felicitas, Wallis Sofia, Davis John M., and Leucht Stefan. 2020. “Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics.” Schizophrenia Bulletin 46 (3): 496–504. 10.1093/schbul/sbz090. - DOI - PMC - PubMed

Publication types